News 08.09.2022 Zurich-Schlieren, Switzerland, September 08, 2022. Proteomedix, a Swiss diagnostics company committed to advance prostate cancer care, announces grant of patent in China for Proclarix®. The China National Intellectual Property Administration notified Proteomedix of the grant of the patent for the invention described in the application No. 201780043349.5, titled “Method of detecting proteins in...
Events, Internal events
Event date: 21.09.2022
Need for speed – How to accelerate bioprocess development with seamlessly integrated data & machine-learning tools
We invite you to an exciting upcoming webinar about the acceleration of bioprocess development with digital solutions. In our newly formed partnership with DataHow AG, we couple Lucullus® to the DataHowLab, a machine learning-based modeling...
Events, Internal events
Event date: 07.09.2022
Time: 13:45 - 16:45 CET
Location: DiNAQOR AG, Wagistrasse 25, 8952 Schlieren
Pushing the Boundaries in Biomolecular Interaction Analysis with the Creoptix WAVEsystem and waveRAPID - From Biologics to Fragment-Based Drug Discovery.
We’re visiting six locations across the EU and the US to deliver the latest insights into binding kinetics and affinity -...
Events, Internal events
Event date: 18.10.2022
Time:
4pm – 5pm CET: Presentation and Q&A
5pm – 7pm CET: Networking session with drinks and snacks
Location:
Bio-Technopark Auditorium, Wagistrasse 25, 8952 Schlieren
Real world evidence is increasingly accepted by regulators and payers and has shown tremendous potential when applied systematically and strategically along the pharmaceutical value chain, becoming an imperative rather than...
News 26.08.2022 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR: Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, today announced its corporate highlights and unaudited financial results for the...